Sequel built its twiist system on underlying drug delivery technology developed by DEKA R&D. Dean Kamen, co-founder of Sequel ...

Insulet (Nasdaq:PODD) announced that it named Lisa Blair Davis as its new SVP and chief human resources officer.

The medtech giant announced in May that it planned to separate the Diabetes unit into a standalone, publicly traded company.

Breakthrough T1D (formerly JDRF) and Mattel announced a partnership to debut the first Barbie doll with type 1 diabetes (T1D) ...

Diabeloop today announced the commercial availability of its DBLG1 algorithm with the Dana-i insulin pump from Sooil in ...

Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor (CGM) implant.

Ypsomed announced today that Chinese regulatory authorities approved the a dual GCP/GLP-1 drug delivered using its ...

Glucotrack (Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.

One of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its capabilities.